Pricing Log in Create free account

Legend Biotech Corporation Sponsored ADR (LEGN) vs Tarsus Pharmaceuticals, Inc. (TARS)

Legend Biotech Corporation Sponsored ADR and Tarsus Pharmaceuticals, Inc. are both Biotechnology companies. Legend Biotech Corporation Sponsored ADR and Tarsus Pharmaceuticals, Inc. are of similar size ($3.8B and $3.5B). Tarsus Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 105.2% against 59.6%. Legend Biotech Corporation Sponsored ADR has the higher net margin (−7.20% vs −7.67%) and the lower return on invested capital (−9.54% vs 0.00%). Across the 17 metrics below, Legend Biotech Corporation Sponsored ADR leads on 9 and Tarsus Pharmaceuticals, Inc. on 8.

Valuation

Metric LEGN TARS Biotechnology median
P/E n/m n/m 8.50
P/S 2.72 4.87 9.71
P/B 2.81 8.52 2.13
Price to free cash flow n/m 62.84 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 2.22 4.25 9.21
Earnings yield (2.68%) (1.60%) (33.15%)
Free cash flow yield (3.54%) 1.59% (25.50%)

Profitability

Metric LEGN TARS Biotechnology median
Gross margin 56.58% 93.28% 65.16%
Operating margin (5.06%) (8.00%) 0.00%
Net margin (7.20%) (7.67%) 0.00%
Free cash flow margin (9.58%) 9.24% 0.00%
Return on equity (8.08%) (13.68%) (56.36%)
Return on assets (5.32%) (8.40%) (48.04%)
Return on invested capital (9.54%) 0.00% 0.00%

Growth

Metric LEGN TARS Biotechnology median
Revenue growth (TTM) 59.55% 105.17% 6.02%
EPS growth (last fiscal year) (66.34%) 48.21% 30.26%
Revenue growth, 5-year CAGR 65.93% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LEGN TARS Biotechnology median
Debt to equity 0.13 0.21 0.00
Current ratio 3.04 3.20 4.72
Net debt to EBITDA 2.31 4.66 0.96

Dividend

Metric LEGN TARS Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric LEGN TARS Biotechnology median
Market cap 3.84b 3.50b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack